Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:885844rdf:typepubmed:Citationlld:pubmed
pubmed-article:885844lifeskim:mentionsumls-concept:C0205054lld:lifeskim
pubmed-article:885844lifeskim:mentionsumls-concept:C0001492lld:lifeskim
pubmed-article:885844lifeskim:mentionsumls-concept:C0012544lld:lifeskim
pubmed-article:885844lifeskim:mentionsumls-concept:C2003941lld:lifeskim
pubmed-article:885844lifeskim:mentionsumls-concept:C1879547lld:lifeskim
pubmed-article:885844lifeskim:mentionsumls-concept:C0525247lld:lifeskim
pubmed-article:885844pubmed:issue15lld:pubmed
pubmed-article:885844pubmed:dateCreated1977-9-22lld:pubmed
pubmed-article:885844pubmed:abstractTextGuanyl-5'-yl-(alpha,beta-methylene)di[gamma-32P]phosphonate (Gp-(CH2)pp) is not hydrolyzed by rat liver membranes under conditions in which GTP and guanyl-5'-yl imidodiphosphate (Gpp(NH)p) are hydrolyzed. Gp(CH2)pp activates adenylate cyclase in hepatic membranes with characteristics similar to those of Gpp(NH)p activation but with lower potency and effectiveness. The analogs, although with lower potency than GTP, also share the ability to change the glucagon receptor from a high to a low affinity state. Both Gp(CH2)pp and Gpp(NH)p stimulate adenylate cyclase activity following a lag period of about 1 min addition of GTP after steady state rates are achieved results in reduction in the rate following a lag period of 6 min from the time of addition of GTP. Pretreatment of the enzyme with Gpp(NH)p or Gp(CH2)pp, followed by washing the membranes, leads to a high activity state of the enzyme which slowly decays in rate unless the analogs are continuously present in the medium. These data suggest that the guanosyl nucleotide analogs act on the enzyme system by a slowly reversible process that possibly reflects slow binding and dissociation from different transition states of the enzyme system and suggest that activation of adenylate cyclase by GTP, Gpp(NH)p, and Gp(CH2)pp does not involve covalent modification of the enzyme.lld:pubmed
pubmed-article:885844pubmed:languageenglld:pubmed
pubmed-article:885844pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:885844pubmed:citationSubsetIMlld:pubmed
pubmed-article:885844pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:885844pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:885844pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:885844pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:885844pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:885844pubmed:statusMEDLINElld:pubmed
pubmed-article:885844pubmed:monthAuglld:pubmed
pubmed-article:885844pubmed:issn0021-9258lld:pubmed
pubmed-article:885844pubmed:authorpubmed-author:RodbellMMlld:pubmed
pubmed-article:885844pubmed:authorpubmed-author:LinM CMClld:pubmed
pubmed-article:885844pubmed:authorpubmed-author:ECKH WHWlld:pubmed
pubmed-article:885844pubmed:authorpubmed-author:LondosCClld:pubmed
pubmed-article:885844pubmed:authorpubmed-author:WeltonA FAFlld:pubmed
pubmed-article:885844pubmed:issnTypePrintlld:pubmed
pubmed-article:885844pubmed:day10lld:pubmed
pubmed-article:885844pubmed:volume252lld:pubmed
pubmed-article:885844pubmed:ownerNLMlld:pubmed
pubmed-article:885844pubmed:authorsCompleteYlld:pubmed
pubmed-article:885844pubmed:pagination5180-2lld:pubmed
pubmed-article:885844pubmed:dateRevised2003-11-14lld:pubmed
pubmed-article:885844pubmed:meshHeadingpubmed-meshheading:885844-A...lld:pubmed
pubmed-article:885844pubmed:meshHeadingpubmed-meshheading:885844-L...lld:pubmed
pubmed-article:885844pubmed:meshHeadingpubmed-meshheading:885844-R...lld:pubmed
pubmed-article:885844pubmed:meshHeadingpubmed-meshheading:885844-K...lld:pubmed
pubmed-article:885844pubmed:meshHeadingpubmed-meshheading:885844-G...lld:pubmed
pubmed-article:885844pubmed:meshHeadingpubmed-meshheading:885844-C...lld:pubmed
pubmed-article:885844pubmed:meshHeadingpubmed-meshheading:885844-G...lld:pubmed
pubmed-article:885844pubmed:meshHeadingpubmed-meshheading:885844-P...lld:pubmed
pubmed-article:885844pubmed:meshHeadingpubmed-meshheading:885844-E...lld:pubmed
pubmed-article:885844pubmed:meshHeadingpubmed-meshheading:885844-G...lld:pubmed
pubmed-article:885844pubmed:meshHeadingpubmed-meshheading:885844-A...lld:pubmed
pubmed-article:885844pubmed:meshHeadingpubmed-meshheading:885844-D...lld:pubmed
pubmed-article:885844pubmed:year1977lld:pubmed
pubmed-article:885844pubmed:articleTitleReversible activation of hepatic adenylate cyclase by guanyl-5'-yl-(alpha,beta-methylene)diphosphonate and guanyl-5'-yl imidodiphosphate.lld:pubmed
pubmed-article:885844pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:885844lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:885844lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:885844lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:885844lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:885844lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:885844lld:pubmed